540 filings
Page 3 of 27
8-K
rgdy vfg8du
23 May 22
Departure of Directors or Certain Officers
4:17pm
8-K
5ztb2pq
4 May 22
Neurocrine Biosciences Reports First Quarter 2022 Financial Results
7:37am
DEFA14A
63tpk91dh3
7 Apr 22
Additional proxy soliciting materials
5:19pm
8-K
c5xio43gofa3hfvi0el
11 Feb 22
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2021 Financial Results and Provides Financial Expectations for Fiscal 2022
7:31am
CT ORDER
gd114lf2eku f5
18 Jan 22
Confidential treatment order
12:00am
8-K
13eqqzxd wpy6wc4kuqo
6 Jan 22
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021 Net Product Sales Results and Future Program Milestones
4:08pm
CT ORDER
2ceit
30 Dec 21
Confidential treatment order
12:00am
8-K
qhlljn75 hrtijwop7
23 Dec 21
Other Events
8:00am
8-K
iig djjz39l
22 Nov 21
Entry into a Material Definitive Agreement
8:01am
UPLOAD
xnh36
15 Nov 21
Letter from SEC
12:00am
CORRESP
ihd3ohz8jrnc4aq
3 Nov 21
Correspondence with SEC
12:00am
8-K
kibh wc56l2tsrg
1 Nov 21
Neurocrine Biosciences Reports Third Quarter 2021 Financial Results
4:03pm
UPLOAD
t4u8kicsq
27 Oct 21
Letter from SEC
12:00am
CORRESP
tkqn1im3 zjfgcis
5 Oct 21
Correspondence with SEC
12:00am
UPLOAD
e4waq76rr14
22 Sep 21
Letter from SEC
12:00am